Skip to main content
NANOVIRICIDES, INC. logo

NANOVIRICIDES, INC. — Investor Relations & Filings

Ticker · NNVC ISIN · US6300873022 LEI · 5493003CK9Y2H0OORR73 US Professional, scientific and technical activities
Open in API
Filings indexed 536 across all filing types
Latest filing 2008-10-01 Regulatory Filings
Country US United States of America
Listing US NNVC

About NANOVIRICIDES, INC.

https://www.nanoviricides.com/

NanoViricides, Inc. is a clinical-stage biopharmaceutical company developing a novel class of nanomedicine-based antiviral therapeutics. The company's proprietary platform technology creates "nanoviricides," which are designed to be broad-spectrum drugs that viruses cannot easily evade through mutation. The technology is biomimetic, mimicking the host cell receptors that viruses use for entry. A nanoviricide is engineered to attract and bind to a virus particle, subsequently trapping and dismantling it to neutralize the threat. The company's development pipeline targets a wide range of viral infections, including respiratory viruses such as RSV, influenza, and coronaviruses, as well as herpesviruses (shingles, cold sores), HIV, and hemorrhagic fever viruses.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, NanoViricides, Inc., could not file its Form 10-K for the year ended June 30, 2008, on time and is requesting an extension. The document does not contain the actual 10-K report or financial data but is merely a notification about the delay in filing the 10-K. According to the MENU VS MEAL RULE, such a notification is not the report itself but an announcement related to the report filing status. Therefore, this document should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories and includes officer certifications, attestations, and notifications like this one.
2008-10-01 English
NANOVIRICIDES 8-K 9-29-2008
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions an interview transcript attached as Exhibit 99.1. The content is a transcript of an interview with the CEO, which aligns with Regulation FD Disclosure. The document is not a full financial report, earnings release, or management discussion but rather a current report disclosing a specific event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. The document length is 2373 characters, which is short and consistent with a regulatory filing rather than a full report.
2008-09-30 English
NANOVIRICIDES INC 8-K 9-9-2008
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions that the filing includes a transcript of an interview with the CEO, attached as Exhibit 99.1. The document is not a full financial report, earnings release, or annual/interim report. It is a regulatory filing to disclose a material event (the interview transcript) under Regulation FD. The document length is 2382 characters, which is relatively short and consistent with a current report rather than a full report. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other categories.
2008-09-09 English
NANOVIRICIDES 8-K 8-27-2008
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the consummation of subscriptions involving the sale of common stock and warrants, including details about the number of shares, exercise prices, and aggregate purchase prices. It also discusses the legal basis for the securities offering (exemptions under the Securities Act) and includes subscription agreements as exhibits. There are no financial statements or comprehensive financial performance data typical of annual or quarterly reports. The document is focused on capital raising activities and changes in the company's capital structure. Therefore, this filing fits the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about financing transactions, not just an announcement or certification, so it is not RPA or RNS. Confidence is high due to clear identification of financing activities and the use of Form 8-K for such disclosures.
2008-08-29 English
NANVIRICIDES, INC 10Q 3-31-2008
Interim / Quarterly Report Q3 2008
2008-05-20 English
Regulatory Filings 2008
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, Nanoviricides Inc., could not file its quarterly report (Form 10-QSB) for the period ended March 31, 2008, within the prescribed time and is requesting an extension. The document does not contain the actual financial data or the quarterly report itself but is a notification about the delay in filing that report. According to the classification rules, such a notification is not the report itself but an announcement related to the filing status. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories and includes officer certifications, attestations, and notifications like Form 12b-25.
2008-05-16 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.